Alithea Genomics is a global leader in scalable transcriptomics solutions for screening applications.
We work with pharma, biotech and agrochemical clients to boost and de-risk their compound selection efforts.

Our high throughput and ultra-low cost library preparation technologies (DRUG-seq) enable RNA-seq data to be generated from several thousands samples in a convenient and streamlined solutions.

Our pipeline does not require RNA extraction and has been validated on several cell lines and organoid types.
On the data analysis side, we provide default upstream, downstream and QC analysis but we also provide bespoke solutions via our team of bioinformatic experts.

In addition to library preparation, sequencing and data analysis, we provide  end-to-end and very high-throughput cell culture, treatment and imaging services (cell painting)